{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:15:13Z","timestamp":1783149313464,"version":"3.54.6"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020205","name":"Health Commission of Jiangxi Province","doi-asserted-by":"publisher","award":["SKJP220203394"],"award-info":[{"award-number":["SKJP220203394"]}],"id":[{"id":"10.13039\/501100020205","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.imbio.2026.153190","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:11:52Z","timestamp":1778548312000},"page":"153190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["ARID1A mutation is associated with an immunosuppressive microenvironment and poor prognosis in hepatocellular carcinoma: An integrated bioinformatics analysis"],"prefix":"10.1016","volume":"231","author":[{"given":"Manxian","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changli","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2026.153190_bb0005","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4049\/jimmunol.1300344","article-title":"Synergistic expression of the CXCL10 gene in response to IL-1\u03b2 and IFN-\u03b3 involves NF-\u03baB, phosphorylation of STAT1 at Tyr701, and acetylation of histones H3 and H4","volume":"191","author":"Burke","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2026.153190_bb0010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-065X.2009.00783.x","article-title":"The CD160, BTLA, LIGHT\/HVEM pathway: a bidirectional switch regulating T-cell activation","volume":"229","author":"Cai","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imbio.2026.153190_bb0015","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1629258","article-title":"High tumor mutation burden predicts better efficacy of immunotherapy: a pooled analysis of 103078 cancer patients","volume":"8","author":"Cao","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.imbio.2026.153190_bb0020","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1158\/2159-8290.CD-18-0567","article-title":"Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis","volume":"9","author":"Carrer","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.imbio.2026.153190_bb0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med."},{"key":"10.1016\/j.imbio.2026.153190_bb0030","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer Immunogenomic analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.imbio.2026.153190_bb0035","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2026.153190_bb0040","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/HEP.0000000000000869","article-title":"Comprehensive molecular classification predicted microenvironment profiles and therapy response for HCC","volume":"80","author":"Chen","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.imbio.2026.153190_bb0045","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.humpath.2024.01.013","article-title":"SWI\/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma: Clinicopathologic and immunohistochemical study","volume":"144","author":"Chen","year":"2024","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.imbio.2026.153190_bb0050","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41419-025-07912-6","article-title":"CHK1 inhibition increases the therapeutic response to radiotherapy via antitumor immunity in ARID1A-deficient colorectal cancer","volume":"16","author":"Chen","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.imbio.2026.153190_bb0055","doi-asserted-by":"crossref","first-page":"1542877","DOI":"10.3389\/fimmu.2025.1542877","article-title":"Perioperative the BTLA inhibitor (tifcemalimab) combined with toripalimab and chemotherapy for resectable locally advanced thoracic esophageal squamous cell carcinoma trial (BT-NICE trial): a prospective, single-arm, exploratory study","volume":"16","author":"Ding","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2026.153190_bb0060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/35051100","article-title":"ICOS co-stimulatory receptor is essential for T-cell activation and function","volume":"409","author":"Dong","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2026.153190_bb0065","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.1038\/s41467-024-50225-z","article-title":"ARID1A safeguards the canalization of the cell fate decision during osteoclastogenesis","volume":"15","author":"Du","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.imbio.2026.153190_bb0070","first-page":"1","article-title":"Genetic alterations in B cell lymphoma subtypes as potential biomarkers for noninvasive diagnosis, prognosis, therapy, and disease monitoring","volume":"44","author":"Esmeray","year":"2020","journal-title":"Turk. J. Biol."},{"key":"10.1016\/j.imbio.2026.153190_bb0075","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1158\/0008-5472.CAN-11-1562","article-title":"ARID1A, a factor that promotes formation of SWI\/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers","volume":"71","author":"Guan","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.imbio.2026.153190_bb0080","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3724\/SP.J.1005.2013.00255","article-title":"Tumor suppressor role of chromatin-remodeling factor ARID1A","volume":"35","author":"Guo","year":"2013","journal-title":"Yi Chuan"},{"key":"10.1016\/j.imbio.2026.153190_bb0085","first-page":"51","article-title":"Clear Cell Adenocarcinoma of the Urinary Tract primary to the Renal Pelvis: a Multi-institutional Clinicopathologic and Molecular Study of five patients","volume":"49","author":"Indulkar","year":"2025","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.imbio.2026.153190_bb0090","doi-asserted-by":"crossref","first-page":"12293","DOI":"10.1073\/pnas.192461099","article-title":"Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade","volume":"99","author":"Iwai","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imbio.2026.153190_bb0095","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.imbio.2026.153190_bb0100","article-title":"Superinduction of immunosuppressive glioblastoma extracellular vesicles by IFN-\u03b3 through PD-L1 and IDO1","volume":"4","author":"Jung","year":"2022","journal-title":"Neuro-Oncol. Adv."},{"key":"10.1016\/j.imbio.2026.153190_bb0105","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/modpathol.2011.161","article-title":"Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma","volume":"25","author":"Katagiri","year":"2012","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.imbio.2026.153190_bb0110","doi-asserted-by":"crossref","first-page":"22330","DOI":"10.1074\/jbc.M111987200","article-title":"SWI\/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription","volume":"277","author":"Lee","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imbio.2026.153190_bb0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/genes15010005","article-title":"The role of the AT-Rich Interaction Domain 1A Gene (ARID1A) in human carcinogenesis","volume":"15","author":"Li","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.imbio.2026.153190_bb0120","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41568-021-00383-9","article-title":"The immunological and metabolic landscape in primary and metastatic liver cancer","volume":"21","author":"Li","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.imbio.2026.153190_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155763","article-title":"Molecular and pathological landscape of the AT-rich interaction domain 1A (ARID1A) mutation in hepatocellular carcinoma","volume":"266","author":"Li","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.imbio.2026.153190_bb0130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12943-019-1062-7","article-title":"Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations","volume":"18","author":"Lin","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.imbio.2026.153190_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/cells9061331","article-title":"Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic strategies","volume":"9","author":"Liu","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.imbio.2026.153190_bb0140","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.7150\/jca.53124","article-title":"LRP1B mutation: a novel independent prognostic factor and a predictive tumor mutation burden in hepatocellular carcinoma","volume":"12","author":"Liu","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.imbio.2026.153190_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146657","article-title":"The comprehensive and systematic identification of BLCA-specific SF-regulated, survival-related AS events","volume":"835","author":"Liu","year":"2022","journal-title":"Gene"},{"key":"10.1016\/j.imbio.2026.153190_bb0150","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1007\/s10528-023-10656-7","article-title":"Uncovering the ceRNA Network Related to the Prognosis of Stomach Adenocarcinoma among 898 Patient Samples","volume":"62","author":"Liu","year":"2024","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.imbio.2026.153190_bb0155","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s10528-023-10516-4","article-title":"Construction of Immune Infiltration-Related LncRNA Signatures based on Machine Learning for the Prognosis in Colon Cancer","volume":"62","author":"Liu","year":"2024","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.imbio.2026.153190_bb0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.imbio.2026.153190_bb0165","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.annonc.2021.02.006","article-title":"High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types","volume":"32","author":"McGrail","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.imbio.2026.153190_bb0170","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/0113892029273682240111052317","article-title":"Analysis of the Expression of PRDX6 in patients with Hepatocellular Carcinoma and its effect on the Phenotype of Hepatocellular Carcinoma Cells","volume":"25","author":"Mu","year":"2024","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.imbio.2026.153190_bb0175","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI31178","article-title":"Indoleamine 2,3-dioxygenase and tumor-induced tolerance","volume":"117","author":"Munn","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2026.153190_bb0180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.32573","article-title":"Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma","volume":"77","author":"Murai","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.imbio.2026.153190_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.654960","article-title":"Roles of BTLA in Immunity and Immune Disorders","volume":"12","author":"Ning","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2026.153190_bb0190","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/1096-9896(200107)194:3<349::AID-PATH887>3.0.CO;2-D","article-title":"Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade","volume":"194","author":"Nocito","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.imbio.2026.153190_bb0195","doi-asserted-by":"crossref","first-page":"1883890","DOI":"10.1080\/2162402X.2021.1883890","article-title":"Phenotypic profiling and prognostic significance of immune infiltrates in esophageal squamous cell carcinoma","volume":"10","author":"Pan","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.imbio.2026.153190_bb0200","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/carcin\/bgw118","article-title":"Frequently mutated genes\/pathways and genomic instability as prevention targets in liver cancer","volume":"38","author":"Rao","year":"2017","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.imbio.2026.153190_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009986","article-title":"Co-existing TP53 and ARID1A mutations promote aggressive endometrial tumorigenesis","volume":"17","author":"Reske","year":"2021","journal-title":"PLoS Genet."},{"key":"10.1016\/j.imbio.2026.153190_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25126601","article-title":"The Immune Checkpoint BTLA in Oral Cancer: Expression Analysis and its Correlation to Other Immune Modulators","volume":"25","author":"Ries","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imbio.2026.153190_bb0215","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","article-title":"Tumor mutational load predicts survival after immunotherapy across multiple cancer types","volume":"51","author":"Samstein","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.imbio.2026.153190_bb0220","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.1038\/s41388-022-02516-2","article-title":"Identification of a novel GR-ARID1a-P53BP1 protein complex involved in DNA damage repair and cell cycle regulation","volume":"41","author":"Stubbs","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.imbio.2026.153190_bb0225","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12943-025-02378-8","article-title":"The tumor microenvironment in hepatocellular carcinoma: mechanistic insights and therapeutic potential of traditional Chinese medicine","volume":"24","author":"Su","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.imbio.2026.153190_bb0230","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imbio.2026.153190_bb0235","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.imbio.2026.153190_bb0240","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1490854","article-title":"Tumor mutational burden is a determinant of immune-mediated survival in breast cancer","volume":"7","author":"Thomas","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.imbio.2026.153190_bb0245","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - a target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.imbio.2026.153190_bb0250","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1158\/0008-5472.CAN-19-3922","article-title":"Loss of ARID1A Promotes Epithelial-Mesenchymal transition and Sensitizes Pancreatic Tumors to Proteotoxic stress","volume":"81","author":"Tomihara","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.imbio.2026.153190_bb0255","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.imbio.2026.153190_bb0260","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.2147\/IJGM.S333390","article-title":"The Mutation and Expression Level of LRP1B are Associated with Immune Infiltration and Prognosis in Hepatocellular Carcinoma","volume":"14","author":"Wang","year":"2021","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.imbio.2026.153190_bb0265","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.1038\/s41467-023-43079-4","article-title":"Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapy","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.imbio.2026.153190_bb0270","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41419-024-06751-1","article-title":"Therapeutic targeting of ARID1A-deficient cancer cells with RITA (Reactivating p53 and inducing tumor apoptosis)","volume":"15","author":"Wang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.imbio.2026.153190_bb0275","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1056\/NEJMc1713444","article-title":"Tumor Mutational Burden and Response Rate to PD-1 Inhibition","volume":"377","author":"Yarchoan","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2026.153190_bb0280","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.3389\/fimmu.2019.02368","article-title":"Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer","volume":"10","author":"Ye","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2026.153190_bb0285","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1158\/1078-0432.CCR-15-0420","article-title":"Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy","volume":"21","author":"Zhai","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.imbio.2026.153190_bb0290","doi-asserted-by":"crossref","DOI":"10.1177\/1533034618754475","article-title":"Loss of ARID1A Expression Correlates with Tumor Differentiation and Tumor Progression Stage in Pancreatic Ductal Adenocarcinoma","volume":"17","author":"Zhang","year":"2018","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.imbio.2026.153190_bb0295","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2147\/JIR.S401123","article-title":"ICOS\/ICOSLG and PD-1 Co-Expression is Associated with the Progression of Colorectal Precancerous- Carcinoma Immune Microenvironment","volume":"16","author":"Zhang","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.imbio.2026.153190_bb0300","article-title":"Targeting WEE1 in ARID1A\/TP53 concurrent mutant Colorectal Cancer by exploiting R-Loop accumulation and DNA repair deficiencies","volume":"13","author":"Zhang","year":"2025","journal-title":"Adv. Sci. (Weinh)."},{"key":"10.1016\/j.imbio.2026.153190_bb0305","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1074\/jbc.M113.532234","article-title":"The induction of lipocalin-2 protein expression in vivo and in vitro","volume":"289","author":"Zhao","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imbio.2026.153190_bb0310","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/15384047.2021.2011643","article-title":"Pan-cancer analysis of ARID family members as novel biomarkers for immune checkpoint inhibitor therapy","volume":"23","author":"Zhu","year":"2022","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.imbio.2026.153190_bb0315","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2174\/0115665232298240240529131358","article-title":"Single-cell and Bulk Transcriptomic analyses Reveal a Stemness and Circadian Rhythm Disturbance-related Signature predicting Clinical Outcome and Immunotherapy Response in Hepatocellular Carcinoma","volume":"25","author":"Zhu","year":"2025","journal-title":"Curr. Gene Ther."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298526000367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298526000367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:17:50Z","timestamp":1783145870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298526000367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0171298526000367"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2026.153190","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ARID1A mutation is associated with an immunosuppressive microenvironment and poor prognosis in hepatocellular carcinoma: An integrated bioinformatics analysis","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2026.153190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153190"}}